- Company Details
DESCRIPTION provided by applicant The high failure rate of drugs in late stage development nearly is a symptom of the inadequacy of pre clinical animal models to accurately predict human biol ...SBIRPhase I2016Department of Health and Human Services National Institutes of Health
DESCRIPTION provided by applicant Only of investigational drugs that enter clinical trials make it to approval Seventy five percent of these failures are due to either unexpected toxicity or l ...SBIRPhase I2015Department of Health and Human Services National Institutes of Health
DESCRIPTION (provided by applicant): The first isolated human hepatoctyte 2D culture, in 1981, provided baseline protocols to support freshly isolated and immediately cultured populations. With cryopr ...SBIRPhase I2011Department of Health and Human Services
SCIKON INNOVATION, INC.
RESEARCH TRIANGLE PARK, NC, 27709-0003
|# of Employees:||1|
|Socially and Economically Disadvantaged:||N|